Orthopedics Articles

Orthopedics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bell TH et al. – Low molecular weight heparins such as dalteparin are the most common form of VTE prophylaxis in Canada. The results suggest that dalteparin use, timing of tourniquet release and house staff turnover can all influence transfusion rates and/or blood loss in patients undergoing primary total joint arthroplasty. This study also emphasizes that women undergoing THA are at particularly high risk for blood transfusion.

Related Articles

How Active are Patients Undergoing Total Joint Arthroplasty?: A Systematic Review
Clinical Orthopedics and Related Research, 11/12/09    Relevance Score: 84%

Today in Clinical Pharmacology...keeping you current

A biodegradable antibiotic delivery system based on poly-for the treatment of osteomyelitis
Acta Orthopaedica, 12/16/09

Concepts for increasing gentamicin release from handmade bone cement beads
Acta Orthopaedica, 12/16/09

Inadequate timing of prophylactic antibiotics in orthopedic surgery. We can do better
Acta Orthopaedica, 12/16/09

Today in Surgical Technique...keeping you current

Proximal Interphalangeal Joint Replacement with Surface Replacement Arthroplasty: Functional Results and Complications
HAND, 12/16/09

Increasing risk of revision due to deep infection after hip arthroplasty
Acta Orthopaedica, 12/16/09

Osteonecrosis following resurfacing arthroplasty
Acta Orthopaedica, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address